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Abstract   
 
Background: Chlamydia and gonorrhea are the 2 most commonly reported sexually 
transmitted infections (STIs) in the United States. Additionally, the number of reported 
cases is lower than the estimated total number of cases due to a variety of factors 
including: unawareness of infection, lack of symptoms, social stigma, and the fact that 
chlamydia and gonorrhea are still not routinely screened for in many clinical settings. 
Past studies suggest that individuals prefer at-home sampling and would even get tested 
more often if STI self-collection were available. Numerous studies investigating the 
effectiveness, screening uptake, and safety of at-home sampling have been performed. 
However, the question of treatment rates in relation to at-home sampling remains. Can 
the use of at-home STI screening for chlamydia and gonorrhea lead to increased rates of 
treatment compared to traditional STI screening methods in sexually active adults?  
 
Methods:  An extensive search was conducted using MEDLINE-PubMed, MEDLINE-
Ovid, and TRIP with the keywords: ((home OR "internet access*" OR "specimen 
handling" OR "self-sampling") AND (screen* OR test*) AND (gonorrhea OR chlamydia) 
AND (treatment OR therapy)). The eligibility criterion was applied to the results and 
duplications were removed. References of selected studies were considered. Quality of 
included studies was assessed using GRADE.  
 
Results:  Two randomized controlled trials (RCTs) met the inclusion and exclusion 
criteria and were included in this systematic review. The first study recruited 2072 
participants who were then randomly allocated to receive a text message with a link 
containing instructions to either complete at home screening (intervention) or clinic-
based screening (control). The proportion of participants treated was 1.1% in the 
intervention group versus 0.7% in the control group. The second study conducted a 
population-based trial that included all people between ages 18-25. The intervention 
group, 10 000 individuals, received information on chlamydia and a mail-back urine 
sampling kit by post. The control group, 31 519 individuals, received nothing by mail and 
was not made aware of the study. The intervention led to 2.5 times more individuals 
receiving treatment.  
 
Conclusion:  At-home chlamydia and gonorrhea sampling may lead to increased rates of 
treatment.  
 
Keywords:  At-home, internet accessed, self-sampling, self-screen, gonorrhea, 
chlamydia, STI, treatment rates  
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Impact of At-Home Versus Clinic-Based Services on 
Chlamydia and Gonorrhea Treatment Rates 
 
BACKGROUND 
 Chlamydia and gonorrhea are the most commonly reported sexually transmitted 
infections (STIs) in the United States with an estimated 2.86 million cases of chlamydia 
and 820 000 cases of gonorrhea occurring annually.1 According to the Center for Disease 
Control and Prevention (CDC), “the number of reported cases is lower than the estimated 
total number because infected people are often unaware of, and do not seek treatment for, 
their infections and because screening for chlamydia is still not routine in many clinical 
settings.”1 Estimates of prevalence are further complicated by the fact that the majority of 
affected people are asymptomatic.2 Research by Banerjee et al3 suggests that “patients 
experiencing symptoms may have reservations about coming to sexual health clinics due 
to social stigma, work and family life restraints.” 
  If left untreated, chlamydia and gonorrhea can cause serious complications. The 
CDC warns that, “untreated, about 10-15% of women with chlamydia will develop pelvic 
inflammatory disease (PID). PID and “silent” infection in the upper genital tract may 
cause permanent damage to the fallopian tubes, uterus, and surrounding tissues, which 
can lead to infertility and/or an increased risk of ectopic pregnancy.”1 Additional 
complications can include facilitation of HIV infection. In males, untreated infection can 
increase risk of epididymitis and prostatitis.2  
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“The current strategy of testing in the health care system includes clinically 
indicated (symptomatic) testing, partner tracing, and opportunistic screening.” 4 This is 
the “clinic-based” or “traditional” model. The United States Preventive Services Task 
force (USPSTF) only recommends screening for chlamydia in sexually active women age 
24 years and younger, and in older women who are at increased risk for infection. In 
men, the USPSTF states that current evidence is insufficient to assess the balance of 
benefits and harms of screening. 5 
With the advent of new technology, self-sampling and self-testing modalities are 
becoming increasingly available to deliver much needed sexual health interventions. 
Harding-Esch et al6 makes an important distinction in that “self-testing differs from self-
sampling”. “Self-testing enables individuals to take a sample, perform a test, and interpret 
the results by themselves, without the need of a laboratory.” Self-sampling allows 
patients to order a test kit from a virtual service (via an app or website), collect their own 
samples, return said samples to a laboratory, and be notified of their results by text 
message or telephone.6 Self-sampling/self-collection was the modality investigated in this 
systematic review.  
Recent studies7 have indicated that some patient demographics prefer at-home 
sampling. Qualitative data collected by Gaydos et al7 suggests that individuals who have 
undergone home-collected sampling prefer the simplicity, security, and privacy of self-
collected specimens. In addition, “when questioned about preference; 94% of women 
answered that they would get tested more often for an STI if self-collection of a vaginal 
swab was available.”8 Numerous studies investigating the effectiveness, screening 
uptake, and safety of at-home sampling have been performed.9 
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Yet, there are still gaps in the research. These digital technologies, while offering 
at-home self-sampling, often require participants with positive test results to seek out a 
sexual health clinic for treatment. It is possible that these patients are lost to follow up. 
Few studies have addressed treatment rates as a primary outcome when comparing at-
home sampling to traditional methods for STI screening. Can the use of at-home STI 
screening for chlamydia and gonorrhea lead to increased rates of treatment compared to 
traditional STI screening methods for sexually active adults?  
METHODS 
An extensive literature review was conducted using MEDLINE - PubMed, 
Evidence-Based Medicine Reviews Multifile-OVID, and the Turning Research into 
Practice (TRIP) databases. The following terms were used in each database to yield a 
comprehensive search: ((home OR "internet access*" OR "specimen handling" OR "self 
sampling") AND (screen* OR test*) AND (gonorrhea OR chlamydia) AND (treatment 
OR therapy)). The references of included articles were also reviewed. Inclusion criteria: 
studies conducted on humans within the last 10 years, randomized controlled trials, and 
studies published in the English language. Exclusion criteria: studies using at-home 
testing for follow up/retesting of previously positive patients instead of as the initial 
screening tool. Quality of the included studies was assessed using the Grading 
Recommendations Assessment, Development and Evaluation (GRADE) Working Group 
guidelines.10 
RESULTS 
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An initial search of 3 databases yielded 177 articles for review. After 22 
duplicates were removed the records were screened using eligibility criteria. The 
bibliographies of eligible articles were reviewed, but did not yield any additional studies. 
Two randomized controlled trials11,4  were ultimately considered for this review. See 
Figure 1 for a search summary. See Table 1 for the quality of reviewed studies. 
Study 1 - Wilson et al:  
This randomized, single blind, controlled trial11 was published in 2017 and took 
place in London. The goals of the study were to assess the effectiveness of an e-STI 
testing and results service on testing uptake and number of STI cases diagnosed. A 
secondary outcome of the study, and the outcome evaluated in this systematic review, 
was the proportion of participants prescribed treatment for an STI.11  
Researchers recruited 2072 participants, ages 16-30 years, in the boroughs of 
Lambeth and Southwark. Both face-to-face and online recruitment strategies were 
employed. Promotional locations included universities, market stalls, barbershops, bars, 
and nightclubs and via Facebook, Twitter, and Grindr (a dating application for gay and 
bisexual men). The study was promoted in conjunction with a health promotion message, 
to motivate participants to join the trial and consider taking an STI test. Participants were 
sent a £10 cash incentive on submission of self-reported data.11  
After recruitment, research assistants assessed eligibility based upon participant 
willingness to take an STI test, access to the Internet, and sexual history of at least one 
partner in the last 12 months. An independent computer-based randomization program 
allocated participants to the intervention (n = 1031) or control groups (n = 1032) and 
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participants were sent text messages with differing URLs depending upon their 
allocation. Laboratory and research staff members were also blinded.11  
The URL of the intervention group directed patients to a website that offered free 
postal self-sampling test kits for chlamydia, gonorrhea, HIV, and syphilis. For chlamydia 
and gonorrhea, women were sent vaginal swabs and men were sent a container for first-
catch urine samples. Test kits for men who have sex with men (MSM) also contained 
swabs to take pharyngeal and rectal samples. Tests kits included pictorial leaflets with 
guidance on how to collect the specimens to ensure accuracy of collection. Test results 
were relayed via text. Patients with positive results were directed to local clinics for 
confirmatory testing and treatment as necessary.11  
Participants in the control group were sent the URL of a website with the contact 
details, and locations of local sexual health clinics. These clinics provided care via walk-
in services free of charge.11  
Researchers collected self-report data about STI diagnosis and treatment, and later 
objectively verified this information in the patient health databases. A statistical analysis 
determined that the proportion of participants treated was 1.1% in the intervention group 
versus 0.7% in the control group (RR 1.72, 95% CI 0.71 to 4.16, P = 0.231). Of note, 
researchers were unable to recruit to target and therefore lacked power.11  
Study 2 - Klovstat et al: 
This population based randomized controlled trial4 was published in 2013 and 
took place in Norway. The goals of the study were to determine whether screening with 
information and home sampling resulted in more young people getting tested, diagnosed, 
and treated for chlamydia in the three months following the intervention compared to the 
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current strategy of testing in the health care system. Treatment rates are the primary 
outcome addressed in this systematic review.4  
A third party randomized everyone between the ages of 18-25 that were listed in 
the population register in Rogaland county, Norway. Unique personal identity numbers 
generated by the national population register were used instead of patient names. The 
total population at this time was 41 793 people. 10 000 people were randomized to the 
intervention group. Individuals in this group were aware of the study and their group 
assignment. The control group received no information about the study. Laboratory 
personnel were aware that mailed urine containers came from participants in the 
intervention group.4  
“People assigned to the intervention group (10 000) received a mail package at 
their home address consisting of: information on the importance of testing and treating 
chlamydia, an invitation to take a home test free of charge, a urine container, a water-
tight plastic container, instructions on how to obtain a first void urine sample, a prepaid 
return envelope, and a questionnaire (socio-demographic details, sexual behavior, 
symptoms (discharge, endocervical bleeding, pelvic pain, urethral itching, dysuria) and 
history of STI).” Participants were instructed to mail the urine samples by post in the 
provided container directly to the laboratory within three months after receiving the 
invitation. No reminders were given. The intervention group was divided into four 
subgroups according to municipality of residence to avoid overloading the lab with 
samples. Letters containing the test result and a contact phone number for support was 
provided to all participants from the diagnosing laboratory. If the test result was positive, 
the participant was requested to visit a clinic for treatment and partner tracing at no cost.4 
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“Participants assigned to the control group (31 519) received no intervention and 
were not informed about the trial and thus continued with the current strategy of testing 
in the health care system. Samples obtained in clinics included either cervical or urethral 
swabs or first void urine samples. Patients with positive test results were, as per current 
routines, contacted by a health professional for treatment and partner tracing. Test and 
treatment services were free of charge. The control group was also followed for 3 months 
and divided into four subgroups according to municipality. An observation period of 
three months was kept consistent between the control and intervention groups.4   
A participant was defined as having been treated for chlamydia if they had filled a 
prescription for a drug against chlamydia within 30 days following a positive test result. 
Information was obtained from the Norwegian Prescription Database (NorPD). The study 
dataset was encrypted, made pseudonymous (by a third party) and merged with NorPD. 
Pseudonyms were removed prior to analysis and no personal identifiers were available to 
researchers. Overall, the intervention led to 2.5 (CI 1.9-3.4) times as many individuals 
receiving treatment for chlamydia compared to the control during the study period.4 
DISCUSSION 
Both studies4,11 included in this review show that the use of at-home STI 
screening for chlamydia and gonorrhea lead to increased rates of treatment in the 
intervention group compared to traditional STI screening methods in sexually active 
adults. This information is clinically relevant because it suggests that at-home or internet 
accessed methods of screening may help decrease the overall prevalence of gonorrhea 
and chlamydia as well as the potential complications from these infections. A summary 
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of the following information and a description of the overall quality of each study can be 
seen in Table 1.  
Limitations 
Potential bias: Wilson et al11 addressed the potential for performance bias and 
states “participants were informed at the time of recruitment that they would be invited 
via text to use one type of sexual health service. The types were not specified outright.” 
The potential for self-reporting bias was present but addressed with objective verification 
of electronic health records. The incentive bias was likewise addressed here: “Participants 
were instructed upon enrollment that the £10 cash incentive was for completing follow 
up. Given that both control and intervention groups were informed, the impact for 
incentivisation should be non-differential and would not explain the result.”11  
Klovstad et al4 risked potential for detection bias because laboratory personnel 
were not blinded to the intervention group. The sample kits mailed to the lab for testing 
were the only at-home kits received throughout the study duration. The randomization 
also produced an imbalance between the groups in regards to municipality of residence. 
However, according to the study “adjustment for municipality in the analysis had 
minimal effects on the risk ratio estimates.” Klovstad et al4 also disclosed the potential 
for contamination in this statement: “with such a large intervention affecting a fourth of 
the population in the target age group, there is bound to have been some “leakage” of 
information to the control group.” 
Methodological limitations: Wilson et al11 used community and social media 
based recruitment strategies then text messaging to deliver screening options to the 
intervention and control groups. Klovstad et al4  attempted to “recruit” every sexually 
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active adult within a target age range and mailed testing kits to the intervention group 
only. These different delivery methods for promoting at-home sampling cannot be 
compared directly.  
In addition, both studies4,11 used a health promotion message in their intervention 
groups to motivate participants to join the trial and consider taking an STI test. It is 
impossible to determine whether the participants completed testing due to the 
intervention or due to the additional health education received. To further complicate 
causality, Wilson et al11 incentivized their participants and all were free to use any other 
sexual health services or interventions during the trial period.  
Wilson et al11 included chlamydia, gonorrhea, HIV, and syphilis in their research. 
Study 2 only addressed chlamydia. For the purposes of this systematic review, the results 
of Klovstad et al4 cannot be extended to include rates of gonorrhea treatment.  
As mentioned previously, Wilson et al11 researchers fell short of their recruitment 
target of 3000 participants. As a result, the study lacked power to detect differences in 
STI cases treated. Participants were free to use any other services or intervention during 
the study period, which introduced potential for contamination.  
Suggestions for Future Research 
Both studies4,11 showed that the proportion of patients treated in the intervention 
group was greater than in the control. However, both studies required participants to seek 
out a traditional clinic for treatment of their positive test result. Wilson et al11 recognizes 
that “it is plausible that whilst the intervention removed the barrier of having to attend a 
clinical service for testing in both studies, the subsequent requirement to attend clinic for 
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treatment may have deterred some participants.” Further investigation and research is 
needed to determine this connection.  
Another important factor requiring exploration is a cost analysis of home-based 
sampling methods/electronically accessed sexual health care compared to traditional 
clinic methods. In both studies, services for at-home and control groups were free. This is 
not an accurate depiction of how care is accessed in many other health care systems. 
Further research is needed to determine the cost effectiveness of these modalities before 
results can be applied to other countries like the United States.  
CONCLUSION 
At-home chlamydia and gonorrhea sampling may lead to increased rates of STI 
treatment. Both studies included in this review showed that the option of at-home 
sampling lead to increased uptake of screening, and that the proportion of patients treated 
in the intervention group was greater than in the control. However, both studies required 
participants to seek out a traditional clinic for treatment of their positive test result. 
Overall study quality was assessed using GRADE and determined to be “High”. Yet, 
further research is required to determine the overall effectiveness and cost benefit of 
using digital modalities over traditional methods for STI screening.  
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Figure 1: Study Search and Selection 
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Table 1: Quality Assessment of Reviewed Articles 
Study Design 
Downgrade Criteria 
Upgrade Criteria Quality 
Limitations Indirectness Inconsistency Imprecision Publication bias 
Wilson et al11 RCT Not serious Not Serious Not Serious Not Serious Unlikely Large Magnitude of effect  
RR = 2.5 
High 
Klovstad et al4 RCT Not Serious Not Serious Not Serious Not Serious Unlikely N/A High 
 
